dc.creator | Duschak, Vilma G | |
dc.date | 2019-12-04T18:54:21Z | |
dc.date | 2019-12-04T18:54:21Z | |
dc.date | 2016 | |
dc.date.accessioned | 2023-08-29T20:06:22Z | |
dc.date.available | 2023-08-29T20:06:22Z | |
dc.identifier | 2212-4071 | |
dc.identifier | http://sgc.anlis.gob.ar/handle/123456789/1428 | |
dc.identifier | 10.2174/1574891X11666161024165304 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8519116 | |
dc.description | Fil: Duschak, Vilma G. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Parasitología; Argentina. | |
dc.description | The American trypanosomiasis, Chagas disease, is a parasitic infection typically spread by triatomine vectors affecting millions of people all over Latin America. Existing chemotherapy is centered on the nitroaromatic compounds benznidazole and nifurtimox that provide unsatisfactory results and substantial side effects. So, the finding and exploration of novel ways to challenge this neglected disease is a main priority. | |
dc.language | en | |
dc.publisher | Bentham Science Publishers | |
dc.relation | Recent patents on anti-infective drug discovery | |
dc.rights | none | |
dc.source | Recent patents on anti-infective drug discovery 2016;11(2):74-173. | |
dc.subject | Trypanosoma cruzi | |
dc.subject | Enfermedad de Chagas | |
dc.subject | Patente | |
dc.title | Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period | |
dc.type | Artículo | |